X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-18 | KYTX | Seidenberg Beth C | Dir | P - Purchase | $7.50 | +133,333 | 4,673,891 | +3% | +$999,998 | ||||||
2025-12-18 | KYTX | Westlake Biopartners Opportunity Fund I, L.P. | 10% | P - Purchase | $7.50 | +133,333 | 4,657,257 | +3% | +$999,998 | ||||||
| D | 2025-12-15 | KYTX | Walker Karen Marie | CTO | S - Sale+OE | $12.20 | -23,998 | 22,636 | -51% | -$292,776 | |||||
| D | 2024-02-12 | KYTX | Vida Ventures, LLC | 10% | P - Purchase | $22.00 | +253,136 | 4,777,060 | +6% | +$5,568,992 | |||||
| D | 2024-02-12 | KYTX | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $22.00 | +450,000 | 3,163,868 | +17% | +$9,900,000 | |||||
| D | 2024-02-12 | KYTX | Gilead Sciences, Inc. | 10% | P - Purchase | $22.00 | +910,000 | 4,126,119 | +28% | +$20,020,000 | |||||
| D | 2024-02-12 | KYTX | Northpond Ventures III Gp, LLC | Former 10% Owner | P - Purchase | $22.00 | +450,000 | 3,255,426 | +16% | +$9,900,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |